SA FLORIDIENNE NV financials
SA FLORIDIENNE NV
Country: BE Reporting currency: EUR Latest annual report: 2025-12-31
LEI:
5493006GUPIIWUHPXP78 Financial statements
(EUR, as reported — unscaled; 119 line items across 2 annual periods)
| Line item | 2025 | 2024 |
|---|---|---|
| Income statement | ||
| Revenue | €725.9M | €697.4M |
| Other income | €15.8M | €18.8M |
| Operating expenses | €631.7M | €599.4M |
| Employee benefits expense | €153.4M | €136.3M |
| Raw materials & consumables used | €334.6M | €325.4M |
| Operating profit (EBIT) | €60.4M | €72.0M |
| Profit before tax | €22.4M | €45.9M |
| Income tax expense | €7.3M | €15.0M |
| Profit for the year | €15.1M | €30.9M |
| — attributable to owners | €7.9M | €15.7M |
| — attributable to NCI | €7.1M | €15.2M |
| Total comprehensive income | -€3.4M | -€35.2M |
| Per share | ||
| Basic EPS | €8.11 | €16.07 |
| Diluted EPS | €8.11 | €16.07 |
| Free cash flow / share | €11.83 | €17.91 |
| Cash flow statement | ||
| Net cash from operating activities | €80.7M | €91.3M |
| Income taxes paid | €19.2M | €7.2M |
| Net cash from investing activities | -€79.8M | -€97.1M |
| Purchase of PP&E (capex) | €58.7M | €56.9M |
| Purchase of intangibles | €14.2M | €10.9M |
| Net cash from financing activities | -€18.2M | €40.9M |
| Dividends paid | €7.2M | €4.7M |
| Proceeds from borrowings | €93.8M | €71.3M |
| Repayments of borrowings | €86.2M | €32.2M |
| Net change in cash | -€17.3M | €35.1M |
| Balance sheet | ||
| Total assets | €1.24B | €1.22B |
| Non-current assets | €865.5M | €831.6M |
| Property, plant & equipment | €195.2M | €162.8M |
| Right-of-use assets | €34.5M | €35.1M |
| Intangible assets & goodwill | €418.3M | €415.1M |
| Current assets | €379.2M | €390.1M |
| Inventories | €99.1M | €91.1M |
| Trade & other receivables | €134.9M | €137.0M |
| Cash & equivalents | €92.9M | €117.3M |
| Total equity | €618.8M | €633.0M |
| — attributable to owners | €369.2M | €379.3M |
| Non-controlling interests | €249.5M | €253.8M |
| Non-current liabilities | €413.7M | €397.0M |
| Long-term borrowings | €279.6M | €267.7M |
| Lease liabilities (non-current) | €29.6M | €30.1M |
| Current liabilities | €212.2M | €191.7M |
| Short-term borrowings | €79.8M | €59.1M |
| Lease liabilities (current) | €8.0M | €7.3M |
| Deferred tax liabilities | €16.0M | €15.4M |
| Derived metrics | ||
| Free cash flow | €22.0M | €34.5M |
| Operating margin | 8.3% | 10.3% |
| Net margin | 2.1% | 4.4% |
| Return on equity | 2.4% | 4.9% |
| Cash conversion ratio | 5.35× | 2.95× |
| Capex coverage | 1.37× | 1.61× |
| Other reported items | ||
| Adjustments For Decrease Increase In Inventories | -€14.0M | -€1.9M |
| Adjustments For Decrease Increase In Trade and Other Receivables | -€16.7M | -€22.7M |
| Adjustments For Finance Income Cost | -€40.4M | -€36.7M |
| Adjustments For Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss Inventories | €3.2M | -€669.0K |
| Adjustments For Increase Decrease In Trade and Other Payables | €14.2M | -€3.2M |
| Adjustments For Losses Gains On Disposal of Noncurrent Assets | -€2.3M | -€1.1M |
| Adjustments For Provisions | €1.1M | €0 |
| Adjustments For Sharebased Payments | €0 | €1.4M |
| Adjustments For Undistributed Profits of Investments Accounted For Using Equity Method | €132.0K | €979.0K |
| Cash Advances and Loans Made To Other Parties Classified As Investing Activities | €955.0K | €215.0K |
| Cash Flows From Losing Control of Subsidiaries Or Other Businesses Classified As Investing Activities | €1.1M | €2.7M |
| Cash Flows From Used In Increase Decrease In Current Borrowings | €22.0M | €7.6M |
| Cash Flows From Used In Operations Before Changes In Working Capital | €97.2M | €119.1M |
| Cash Flows Used In Obtaining Control of Subsidiaries Or Other Businesses Classified As Investing Activities | €9.0M | €31.1M |
| Cash Receipts From Repayment of Advances and Loans Made To Other Parties Classified As Investing Activities | €15.0K | €403.0K |
| Comprehensive Income Attributable To Noncontrolling Interests | -€630.0K | -€18.7M |
| Comprehensive Income Attributable To Owners of Parent | -€2.7M | -€16.5M |
| Current Biological Assets | €6.0M | €5.8M |
| Current Government Grants | €565.0K | €698.0K |
| Current Provisions | €1.1M | €1.8M |
| Current Recognised Liabilities Defined Benefit Plan | €1.7M | €1.5M |
| Current Tax Assets Current | €25.2M | €19.0M |
| Current Tax Liabilities Current | €15.5M | €19.2M |
| Deferred Tax Assets | €27.2M | €19.8M |
| Depreciation Amortisation and Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | €49.6M | €44.8M |
| Dividends Paid To Equity Holders of Parent Classified As Financing Activities | €2.9M | €2.4M |
| Dividends Paid To Noncontrolling Interests Classified As Financing Activities | €4.3M | €2.3M |
| Dividends Proposed Or Declared Before Financial Statements Authorised For Issue But Not Recognised As Distribution To Owners | €2.9M | — |
| Dividends Proposed Or Declared Before Financial Statements Authorised For Issue But Not Recognised As Distribution To Owners Per Share | €0.30 | — |
| Dividends Received Classified As Investing Activities | €624.0K | €0 |
| Dividends Recognised As Distributions To Owners Per Share | €3.00 | — |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | -€7.1M | -€4.8M |
| Equity and Liabilities | €1.24B | €1.22B |
| Gains Losses On Disposals of Noncurrent Assets | €2.2M | €1.1M |
| Increase Decrease In Working Capital | €16.5M | €27.8M |
| Increase Decrease Through Changes In Ownership Interests In Subsidiaries That Do Not Result In Loss of Control | -€464.0K | -€2.7M |
| Increase Decrease Through Sharebased Payment Transactions | €0 | €1.4M |
| Inflows of Cash From Investing Activities | €5.1M | €6.5M |
| Intangible Assets Other Than Goodwill | €170.6M | €175.0M |
| Interest Expense | €26.7M | €25.7M |
| Interest Paid Classified As Financing Activities | €39.2M | €36.7M |
| Investment Accounted For Using Equity Method | €3.4M | €5.4M |
| Liabilities | €625.9M | €588.8M |
| Noncurrent Government Grants | €3.5M | €3.9M |
| Noncurrent Provisions | €1.1M | €563.0K |
| Noncurrent Recognised Liabilities Defined Benefit Plan | €2.2M | €2.2M |
| Other Adjustments To Reconcile Profit Loss | €2.2M | €268.0K |
| Other Components of Other Comprehensive Income That Will Be Reclassified To Profit Or Loss Net of Tax | -€461.0K | €0 |
| Other Comprehensive Income | -€18.4M | -€66.1M |
| Other Comprehensive Income Net of Tax Cash Flow Hedges | €2.6M | €99.0K |
| Other Comprehensive Income Net of Tax Exchange Differences On Translation | -€20.6M | -€66.2M |
| Other Comprehensive Income Net of Tax Gains Losses On Remeasurements of Defined Benefit Plans | €0 | €0 |
| Other Current Assets | €20.5M | €19.4M |
| Other Current Financial Assets | €567.0K | €547.0K |
| Other Current Liabilities | €40.6M | €40.5M |
| Other Expense By Nature | €143.7M | €137.7M |
| Other Finance Income Cost | -€13.7M | -€2.5M |
| Other Noncurrent Assets | €16.3M | €18.3M |
| Other Noncurrent Liabilities | €81.7M | €77.2M |
| Outflows of Cash From Investing Activities | €84.9M | €103.6M |
| Payments From Changes In Ownership Interests In Subsidiaries | €1.0M | €6.2M |
| Proceeds From Contributions of Noncontrolling Interests | €0 | €40.0M |
| Proceeds From Government Grants Classified As Financing Activities | €25.0K | €1.6M |
| Proceeds From Sales of Intangible Assets Classified As Investing Activities | €324.0K | €0 |
| Proceeds From Sales of Property Plant and Equipment Classified As Investing Activities | €3.0M | €3.5M |
| Purchase of Investments Other Than Investments Accounted For Using Equity Method | €2.0M | €4.4M |
| Revenue and Operating Income | €741.7M | €716.2M |
| Share of Profit Loss of Associates and Joint Ventures Accounted For Using Equity Method | €132.0K | €979.0K |
| Trade and Other Current Payables To Trade Suppliers | €64.9M | €61.6M |
Methodology
Every line item above is a fact tagged in SA FLORIDIENNE NV's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (EUR), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.